Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres

Abstract

MiNEN is most commonly driven by a poorly differentiated neuroendocrine component, and has poor prognosis. Advances in its biological understanding are needed to identify effective treatments and improve patient outcomes.